Related Experiment Videos
[Nephrotoxicity test on T-3262 in rats with experimental nephropathy]
A Nagai1, M Nagasawa, S Ooyama
1Research Laboratory, Toyama Chemical Co. Ltd.
The Japanese Journal of Antibiotics
|April 1, 1989
Summary
The new antibacterial agent T-3262 did not worsen kidney damage in rats with experimental nephropathy induced by mercuric chloride or puromycin-aminonucleoside.
Area of Science:
- Pharmacology
- Toxicology
- Nephrology
Context:
- Experimental nephropathy models are crucial for evaluating drug safety.
- Mercuric chloride (HgCl2) and puromycin-aminonucleoside (PAN) are common agents to induce kidney damage in rats.
- Assessing the renal safety of novel antibacterial agents is essential.
Purpose:
- To investigate the potential nephrotoxicity of the synthetic antibacterial agent T-3262.
- To determine if T-3262 exacerbates existing kidney injury in rat models of nephropathy.
- To evaluate the effects of T-3262 on renal function and pathology.
Summary:
- Male rats with HgCl2- or PAN-induced nephropathy were administered T-3262 orally (1,000 mg/kg/day) for 2 or 6 days.
- Kidney function tests, weight, and histopathology were assessed 24 hours after the last T-3262 dose.
- T-3262 did not cause significant alterations in renal parameters or exacerbate HgCl2- or PAN-induced nephropathy.
Impact:
- This study suggests T-3262 exhibits a favorable renal safety profile at the tested dose.
- Findings support the further development of T-3262 as a potential antibacterial therapeutic.
- Provides valuable data on the non-nephrotoxic potential of novel synthetic antibacterials.